European Union · Question · QUESTION_WRITTEN
E-9-2022-003436
Haftungsbedingungen der Mitgliedstaaten hinsichtlich der COVID-19-Impfstoffe – Teil 2
Introduced
20 October 2022
Last action
16 January 2023 · Answer
Status
answered
Sponsors
Christine ANDERSON
Subjects
Discovery layer
Source updated
16 January 2023
Records
Official question E-9-2022-003436 from European Union at European Parliament. Dated 20 October 2022. Status: answered.
Timeline
20 October 2022
Written question
Haftungsbedingungen der Mitgliedstaaten hinsichtlich der COVID-19-Impfstoffe – Teil 2
Source: QUESTION_WRITTEN
16 January 2023
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Answer
This file cannot be previewed here. Use View or Download.
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Answer
QUESTION_WRITTEN_ANSWER · 16 January 2023
Conditions for liability of the Member States with regard to COVID-19 vaccines – Part 2
QUESTION_WRITTEN · EN · 27 October 2022
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Conditions for liability of the Member States with regard to COVID-19 vaccines – Part 2
QUESTION_WRITTEN · EN · 27 October 2022
DownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Conditions for liability of the Member States with regard to COVID-19 vaccines – Part 2
QUESTION_WRITTEN · EN · 27 October 2022
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Haftungsbedingungen der Mitgliedstaaten hinsichtlich der COVID-19-Impfstoffe – Teil 2
QUESTION_WRITTEN · DE · 27 October 2022
DownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Haftungsbedingungen der Mitgliedstaaten hinsichtlich der COVID-19-Impfstoffe – Teil 2
QUESTION_WRITTEN · DE · 27 October 2022
ViewDownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Haftungsbedingungen der Mitgliedstaaten hinsichtlich der COVID-19-Impfstoffe – Teil 2
QUESTION_WRITTEN · DE · 27 October 2022
ViewDownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Sponsors
- · COM · ADDRESSEE
- · EU_COMMISSION · ADDRESSEE
- Christine ANDERSON · AUTHOR
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/E-9-2022-003436_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/E-9-2022-003436
- eu · E-9-2022-003436 · source updated 16 January 2023